Objective and noninvasive detection of sub-clinical lung injury in breast cancer patients after radiotherapy

Eur J Surg Oncol. 2005 Nov;31(9):954-7. doi: 10.1016/j.ejso.2005.07.006. Epub 2005 Aug 15.

Abstract

Aims: We employed technetium-99m hexamethylpropylene amine oxime (Tc-99m HMPAO) lung scan to detect sub-clinical lung injury after radiation therapy of 60 female patients diagnosed with right breast cancer.

Methods: The degree of pulmonary vascular endothelium damage was represented as lung/liver uptake ratios (L/L ratios) calculated on Tc-99m HMPAO lung scan. All patients underwent simple mastectomy and post-operative radiotherapy of approximately 50 Gy. We divided the patients into three groups according to the interval between radiotherapy and lung Tc-99m HMPAO lung scan: Group 1 included 20 patients who received the lung scan within 1-3 months after radiotherapy, group 2 included 20 patients were within 3-9 months after radiotherapy, and group 3 included 20 patients were more than 9 months after radiotherapy. In addition, 20 age-matched normal women were included as the control group.

Results: The L/L ratios were 0.32+/-0.04 for normal controls, 0.59+/-0.10 for group 1, 0.55+/-0.07 for group 2, and 0.34+/-0.04 for group 3, respectively. Based on our preliminary results, we found that sub-clinical lung injury and significantly increased L/L ratio in breast cancer patients received radiotherapy may occur within the first 6 months after radiotherapy. However, the L/L ratio is markedly decreased after 9 months.

Conclusion: Our findings concluded that the degree of pulmonary vascular endothelium damage represented as the L/L ratio on Tc-99m HMPAO lung scan has the potential to be a sensitive, objective and noninvasive method to detect sub-clinical lung injury in breast cancer patients received radiotherapy.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / radiotherapy*
  • Endothelium, Vascular / radiation effects*
  • Female
  • Humans
  • Lung / blood supply
  • Lung / radiation effects*
  • Middle Aged
  • Radiation Injuries / diagnostic imaging*
  • Radiation Injuries / etiology
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Radiotherapy / adverse effects
  • Technetium Tc 99m Exametazime

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Exametazime